Related by context. All words. (Click for frequent words.) 72 ISIS # 70 Mipomersen 69 Phenoptin 69 severe hypercholesterolemia 68 Corlux 68 phase IIb 67 darapladib 67 eltrombopag 67 daclizumab 67 ocrelizumab 67 Phase 2b trial 66 darusentan 66 HoFH 66 Kuvan 66 phase IIb clinical 66 axitinib 66 eprotirome 66 JAK inhibitor 66 BAY #-# 66 Phase Ib 66 elotuzumab 66 bicifadine 66 PEG PAL 66 rNAPc2 65 Ranexa 65 Phase III trials 65 muraglitazar 65 alogliptin 65 phase IIb trial 65 lintuzumab 65 LAF# 65 pivotal Phase III 64 Nuvion 64 maribavir 64 HuMax CD4 64 Phase IIb trial 64 dirucotide 64 heterozygous FH 64 phase IIa clinical 64 Icatibant 64 Zalbin 64 Phase Ib study 64 tofacitinib 64 GALNS 64 Phase 2b study 64 LymphoStat B 64 ponatinib 64 PREOS 64 carfilzomib 64 registrational 64 enzastaurin 64 StaphVAX 64 BCX# 64 ruboxistaurin 64 Amigal 64 Asentar 64 AMR# 64 INCB# [001] 64 Qnexa 64 Desmoteplase 64 ambrisentan 64 midstage clinical 63 Galvus 63 iloperidone 63 QAB# 63 Trexima 63 AEGR 63 HuMax CD# 63 alvimopan 63 mixed dyslipidemia 63 HuLuc# 63 Phase III 63 AP# [003] 63 PS# [001] 63 Phase III clinical trials 63 tasocitinib 63 phase IIa 63 bardoxolone 63 Phase #b/#a 63 Phase III clinical 63 Targretin 63 Treanda 63 valopicitabine 63 diabetic neuropathic pain 63 Phase IIb 63 pradefovir 63 MDV# 63 Folotyn 63 exenatide 63 Saxagliptin 63 registrational trial 63 QNEXA 63 ularitide 63 HuMax EGFr 63 Marqibo 63 DCCR 63 liprotamase 63 Arcalyst 63 vilazodone 63 Zerenex 63 bapineuzumab 63 teduglutide 63 PEG Interferon lambda 63 lupus nephritis 63 Phase Ib clinical 63 vicriviroc 63 Reverset 63 Tyrima 63 lomitapide 63 rALLy trial 63 CoFactor 63 otelixizumab 63 Genz # 62 INCB# [002] 62 Cinquil 62 selective androgen receptor modulator 62 PRX # 62 ganetespib 62 atrasentan 62 dacetuzumab 62 dose cohorts 62 Dapagliflozin 62 alvespimycin 62 glufosfamide 62 Amrubicin 62 Phase 2a trial 62 oral ridaforolimus 62 betrixaban 62 ALKS 62 lixisenatide 62 GSK# [002] 62 Phase 1b trial 62 MYDICAR 62 ATL# [001] 62 LY# [003] 62 alemtuzumab 62 Ambrisentan 62 ataluren 62 sapacitabine 62 taranabant 62 DPP4 inhibitor 62 Allovectin 7 R 62 nebivolol 62 methylnaltrexone 62 Albuferon 62 NGX# 62 Liraglutide 62 DR Cysteamine 62 ITAX 62 Viramidine 62 lumiliximab 62 KRN# 62 Bicifadine 62 Phase 2b clinical 62 Phase IIa trial 62 danoprevir 62 RG# [001] 62 homozygous familial hypercholesterolemia 62 ALN PCS 62 Phase IIa clinical 62 MBP# [001] 62 celgosivir 62 midstage studies 62 NVA# 62 Antegren 62 Epanova 62 Laquinimod 62 asenapine 62 velaglucerase alfa 62 phase Ib 62 VEGF Trap 62 placebo controlled Phase 62 CRx 62 deforolimus 62 TELINTRA 62 pegloticase 62 BYDUREON 61 TACI Ig 61 Pimavanserin 61 EOquin 61 Dacogen injection 61 Fablyn 61 Troxatyl 61 Phase 2a 61 atacicept 61 Promacta 61 Fampridine SR 61 faropenem 61 visilizumab 61 neratinib 61 CORLUX 61 bifeprunox 61 dimebon 61 Heplisav 61 HspE7 61 Egrifta 61 Phase IIa trials 61 Northera 61 TOCOSOL Paclitaxel 61 Acapodene 61 FM VP4 61 JANUVIA 61 ASA# 61 linagliptin 61 RSD# 61 tezampanel 61 perifosine 61 Bydureon 61 Syncria 61 Dacogen 61 FTY# 61 tanezumab 61 AeroLEF TM 61 ruxolitinib 61 Aegerion 61 Tocosol Paclitaxel 61 Plicera 61 baminercept 61 Sulonex 61 Aurexis 61 Phase IIb trials 61 exenatide LAR 61 ILLUMINATE 61 anidulafungin 61 Celgene Revlimid 61 Phase 1a clinical 61 regorafenib 61 Leukine 61 Phase 1b 61 arzoxifene 61 omacetaxine 61 Telaprevir 61 Relovair 61 Allovectin 7 61 Riquent 61 Rezular 61 ipilimumab 61 TBC# 61 PLK1 SNALP 61 vemurafenib 61 forodesine 61 Phase 2b 61 teriflunomide 61 Clolar 61 EVIZON 61 telaprevir 61 AEG# 61 maraviroc 61 orBec 61 XL# [003] 61 Golimumab 61 panitumumab 61 rindopepimut 61 TroVax 61 experimental hepatitis C 61 telcagepant 61 glucokinase activator 61 picoplatin 61 Rasilez 60 PROMACTA 60 albinterferon alfa 2b 60 bazedoxifene 60 Santhera 60 Phase IIa 60 olaparib 60 Contrave 60 Omacetaxine 60 zileuton CR 60 GATTEX 60 Certriad 60 tanespimycin 60 peginesatide 60 Ophena TM 60 confirmatory Phase III 60 Technosphere Insulin 60 BRIM3 60 IDX# 60 teplizumab 60 reslizumab 60 Canvaxin 60 lasofoxifene 60 FOLOTYN 60 metaglidasen 60 Numax 60 Tekamlo 60 phase IIb study 60 prasugrel 60 cilengitide 60 Campath 60 ZOLINZA 60 vosaroxin 60 CEQ# 60 tafamidis 60 pirfenidone 60 Exforge 60 PRTX 60 clinical trials 60 Jevtana 60 Ocrelizumab 60 Ventavis 60 Iloperidone 60 Phase IIIb clinical 60 linaclotide 60 EndoTAG TM -1 60 febuxostat 60 omacetaxine mepesuccinate 60 ridaforolimus 60 lesinurad 60 L BLP# 60 ProSavin 60 Hematide 60 Naproxcinod 60 PF # [001] 60 PREOS R 60 regadenoson 60 Firazyr 60 Nasulin 60 voreloxin 60 Aryplase 60 R#/MEM # 60 AVE# 60 SCH # 60 SAR# [004] 60 dose cohort 60 ORENCIA R 60 rhThrombin 60 abiraterone 60 Dalbavancin 60 Entereg 60 Insegia 60 Lupuzor 60 lorcaserin 60 BENLYSTA ® 60 phase 2a 60 Vidaza 60 apixaban 60 aflibercept 60 thymalfasin 60 MERLIN TIMI 60 PhosLo 60 Levadex 60 figitumumab 60 Advexin 60 Xyotax 60 davunetide 60 Gattex 60 QVA# 60 Vicriviroc 60 BRIM2 60 ELACYT 60 saxagliptin 60 Revlimid 60 Preos 60 vismodegib 60 APD# 60 renin inhibitor 59 crofelemer 59 ELADUR 59 pramlintide 59 MK #A [001] 59 aleglitazar 59 clinical trial 59 TMC# [002] 59 Oglemilast 59 oral methylnaltrexone 59 XmAb# 59 Huntexil 59 pralatrexate 59 Ceflatonin 59 YONDELIS 59 Serdaxin 59 Sorafenib 59 evaluating tivozanib 59 Annamycin 59 Milnacipran 59 PRT# 59 blinatumomab 59 Puricase 59 fidaxomicin 59 eniluracil 59 dapagliflozin 59 HZT 59 tivozanib 59 clofarabine 59 Prestara 59 ozarelix 59 ofatumumab 59 Vilazodone 59 HGS ETR1 59 Zolinza 59 PHX# 59 terlipressin 59 midstage trials 59 aliskiren 59 TriLipix 59 Cerovive 59 sunitinib malate 59 Azedra 59 lintuzumab SGN 59 Actemra 59 elagolix 59 Onco TCS 59 retigabine 59 lurasidone 59 Ereska 59 motesanib 59 Phase 2b clinical trials 59 pulmonary arterial hypertension 59 HGS# 59 Pivotal Phase III 59 ZYBRESTAT 59 FOLOTYN ® 59 Torisel 59 Gabapentin GR 59 Tyvaso 59 PTK ZK 59 Arranon 59 Xinlay 59 EDEMA4 59 rolofylline 59 obatoclax 59 CYCLOSET 59 Macugen 59 Viprinex 59 Azixa 59 LibiGel ® 59 Dasatinib 59 Pirfenidone 59 denosumab 59 SinuNase 59 investigational compound 59 TYZEKA 59 tecarfarin 59 Ostarine 59 Mycograb 59 Phase IIb clinical trials 59 MAA submission 59 ALN TTR 59 canagliflozin 59 pomalidomide 59 motavizumab 59 Kynapid 59 CCX# 59 entinostat 59 SILENOR 59 Muraglitazar 59 PDE4 inhibitor 59 Ceplene 59 midstage study 59 ImClone Erbitux 59 pegylated interferons 59 CDP# 59 Phase 2a clinical 59 avanafil 59 ospemifene 59 ThGRF 59 liraglutide 59 Phase Ib II 59 Bezielle 59 Stedivaze 59 PrevOnco 59 odanacatib 59 Vernakalant 59 belinostat 59 Civacir 59 Cetrorelix 59 T DM1 59 talactoferrin 59 AZD# 59 EDEMA3 59 Genasense 59 Diamyd ® 59 Nuedexta 59 Cushing Syndrome 59 Affinitak 59 Vertex Pharma 59 clazosentan 59 TREANDA 59 vandetanib 59 Zensana TM 59 SARMs 59 cannabinor 59 ixabepilone 59 RGB # 59 NV1FGF 59 OXi# 59 Evoltra 59 ADVEXIN 59 Zadaxin 59 Remodulin 59 KNS # 59 ALN VSP 59 EOquin TM 59 Evoltra TM 59 gefitinib Iressa 59 pharmacokinetic PK 59 IMA# 59 brivaracetam 59 dalbavancin 59 Aptivus 59 Alnara 59 Abiraterone acetate 59 zanolimumab 59 amrubicin 59 solanezumab 59 Darusentan 58 tezampanel NGX# 58 primary hypercholesterolemia 58 riociguat 58 Pivotal Phase 58 hoFH 58 BENLYSTA 58 clinical pharmacology studies 58 Acetavance 58 torezolid phosphate 58 pertuzumab 58 cediranib 58 posaconazole 58 Alfimeprase 58 Xiaflex 58 Serada 58 MGCD# [001] 58 LibiGel Phase III 58 Vectibix panitumumab 58 custirsen 58 Virulizin 58 LY# [002] 58 Onrigin 58 PXD# 58 OvaRex ® MAb 58 Satraplatin 58 Degludec 58 Atrasentan 58 MAGE A3 ASCI 58 sitaxsentan 58 Medidur FA 58 ELND# 58 ASONEP 58 Phase IIB 58 Neurodex 58 TELCYTA 58 SUCCEED trial 58 ApoB SNALP 58 Phase IIIb 58 Phase IIb clinical 58 Revlimid lenalidomide 58 SPP# [001] 58 Rhucin 58 temsirolimus 58 Benlysta belimumab 58 TOLAMBA 58 blood clot preventer 58 Cimzia TM 58 Anacetrapib 58 ranolazine 58 Campath alemtuzumab 58 exenatide once 58 tamibarotene 58 NUVIGIL 58 Cethromycin 58 Elagolix 58 Horizant 58 iniparib 58 eosinophilic asthma 58 cangrelor 58 squalamine 58 brentuximab 58 Avanafil 58 torcetrapib atorvastatin 58 relapsing remitting multiple sclerosis 58 Betaferon 58 canakinumab 58 acyclovir Lauriad R 58 Oral NKTR 58 Vitaxin 58 alemtuzumab MS 58 eculizumab 58 Arxxant 58 Rebif ® 58 Xanafide 58 IL# PE#QQR 58 sunitinib 58 telavancin 58 vernakalant 58 Bronchitol 58 MAP# 58 Plenaxis TM 58 Immunomedics 58 Archexin 58 Velcade bortezomib 58 CR# vcMMAE 58 Alzhemed TM 58 tolvaptan 58 Zybrestat 58 huC# DM4 58 Increlex 58 Herceptin trastuzumab 58 HepeX B 58 PSN# [002] 58 MOZOBIL 58 nalbuphine ER 58 dextromethorphan quinidine 58 RSR# 58 Nexavar ® 58 R sorafenib tablets 58 Sym# 58 Lenocta 58 Neulasta ® 58 iclaprim 58 brentuximab vedotin 58 Valsartan 58 Selzentry 58 Romidepsin 58 RELOVAIR ™ 58 fenofibrate 58 Triapine 58 tolevamer 58 rilonacept 58 cobiprostone 58 pafuramidine 58 SNT MC# 58 APPRAISE 58 neurogenic orthostatic hypotension 58 Vectibix 58 IND submission 58 fostamatinib 58 ATryn R 58 Lorcaserin 58 Aclidinium 58 Fampridine 58 refractory APL 58 Evoltra ® 58 Urocortin 2 58 Phase Ia 58 anacetrapib 58 Randomized Phase 58 MEK inhibitor 58 randomized Phase IIb 58 RDEA# 58 relapsed multiple myeloma 58 ISENTRESS 58 TRISENOX 58 Exherin TM 58 pivotal bioequivalence 58 Stelara 58 HQK 58 Torcetrapib 58 ATryn ® 58 aclidinium bromide 58 Daclizumab 58 Afinitor 58 Yervoy 58 RSD# oral 58 incyclinide 58 Soliris 58 Solzira 58 THALOMID 58 SRT# [003] 58 Fodosine 58 OMAPRO 58 Clonicel 58 Krystexxa 58 PEG INTRON 58 abiraterone acetate 58 Lu AA# 58 sitagliptin 58 JAK2 inhibitor 58 fenofibric acid 58 multicenter Phase 58 oxymorphone ER 58 crizotinib 58 Treximet 58 Zemplar Capsules 58 XL# XL# XL# XL# 58 bevacizumab Avastin 58 Fibrillex TM 58 volociximab 58 Maximum Tolerated Dose 58 valsartan 58 tremelimumab 58 cancer neuroendocrine tumor 57 Traficet EN 57 MNTX 57 Tykerb 57 RhuDex 57 treprostinil 57 Roche Actemra 57 Eliquis 57 Exenatide LAR 57 Tekturna 57 Dynogen 57 Factive 57 Aliskiren 57 laquinimod 57 ecallantide 57 satraplatin 57 Orazol 57 Telavancin 57 compound INCB# 57 TREDAPTIVE 57 dexanabinol 57 milnacipran 57 Ruconest 57 romiplostim 57 Trizytek 57 telbivudine 57 BEMA Buprenorphine 57 IMGN# 57 Phase 1b clinical 57 TKM ApoB 57 Rasilez Tekturna 57 IMC #B 57 Cethrin 57 ISTODAX 57 lymphoma CTCL 57 Telcyta 57 Phase #b/#a trial 57 Tezampanel 57 MyVax 57 ONTAK 57 Androxal 57 Tesetaxel 57 TORISEL 57 bosutinib 57 romidepsin 57 CRD5 57 MYDICAR ® 57 Balaglitazone 57 Clolar ® 57 TRIOLEX 57 Pafuramidine 57 investigational monoclonal antibody 57 sorafenib Nexavar 57 Octreolin 57 roflumilast 57 Actimmune ® 57 Ixempra 57 Iluvien ® 57 Restanza 57 VPRIV 57 Exelixis XL# 57 Actilon 57 ADX# 57 Onglyza 57 Tarceva 57 Abraxane 57 Mylotarg 57 rFIXFc 57 MAXY G# 57 naproxcinod 57 Alzhemed 57 DU #b 57 fenretinide 57 ORAL Sync 57 Arixtra 57 Preotact 57 Exenatide 57 Locteron 57 Fx #A 57 Pazopanib 57 Cloretazine R VNP#M 57 alfimeprase 57 Avastin bevacizumab 57 Sular formulation 57 Targretin capsules 57 Virulizin R 57 Phase III Clinical Trials 57 Tygacil 57 Tofacitinib 57 mertansine 57 Sprycel 57 investigational drug 57 retinal vein occlusion 57 pitavastatin 57 Pivotal Trial 57 Onbrez Breezhaler 57 carcinoid syndrome 57 pexelizumab 57 OvaRex R 57 HCV SPRINT 57 fluvastatin 57 Panzem 57 Arzerra 57 tesmilifene 57 COMFORT II 57 midstage clinical trial 57 Recentin 57 GW# [003] 57 cetrorelix 57 ustekinumab 57 Zensana 57 sodium glucose cotransporter 57 rALLy 57 ATL/TV# 57 refractory gout 57 sorafenib tablets 57 AERx iDMS 57 Zactima 57 Junovan 57 StaphVax 57 Menerba 57 toremifene 57 BRAF inhibitor 57 Nebido 57 virus HCV protease inhibitor 57 Cimzia 57 Nexavar 57 Triolex 57 NP2 Enkephalin 57 E2F Decoy 57 MK #B 57 tocilizumab 57 GVAX 57 Xgeva 57 Febuxostat 57 generation purine nucleoside 57 Aggrastat 57 Dimebon 57 oral deforolimus 57 randomized Phase 57 zalutumumab 57 Atacand 57 Eltrombopag 57 JAK inhibitors 57 QuatRx 57 Tekturna HCT 57 Cloretazine ® 57 Zenvia ™ 57 Tavocept 57 NATRECOR R 57 Flutiform 57 azilsartan medoxomil 57 BENICAR HCT 57 Denosumab 57 EGS# 57 Aflibercept 57 Tracleer 57 Azedra TM 57 HCV protease inhibitor 57 DASISION 57 pimavanserin 57 EP #R 57 enoximone 57 Ilaris 57 OMNARIS HFA 57 Itopride 57 APTIVUS 57 Firdapse 57 PEG SN# 57 Sanctura XR 57 azacitidine 57 oral prodrug 57 Cloretazine 57 #D#C# 57 docetaxel Taxotere R 57 FoldRx 57 PRISTIQ 57 Phase 1a 57 Kalbitor 57 Belinostat 57 investigational compounds 57 Urocidin 57 diabetic macular edema 57 IAP inhibitors 57 Oxypurinol 57 Joulferon 57 Tolerx 57 investigational oral therapy 57 Afresa 57 cetuximab Erbitux 57 IMC A# 57 Phase IIa clinical trials 57 UPLYSO 57 ALTU 57 tiapamil 57 cinacalcet HCl 57 AQ4N 57 orally bioavailable 57 Sycrest 57 lixivaptan 57 SILENOR TM 57 BARACLUDE R 57 myelofibrosis 57 Pradefovir 57 hereditary angioedema 57 ezogabine 57 elesclomol 57 ceftaroline 57 trastuzumab DM1 57 octreotide implant 57 eliglustat tartrate 57 DDP# 57 OMAPRO ™ 57 Panzem R NCD 57 sargramostim 57 Maribavir 57 CD# antibody [001] 57 Azacitidine 57 MLN# 57 APEX PD 57 budesonide foam 57 LUCENTIS 57 non metastatic osteosarcoma 57 ALN TTR# 57 IRX 2 57 Stimuvax R 57 NDA submission 57 Orathecin 57 dose escalation trial 57 LymphoStat B TM 57 CTAP# Capsules 57 Onyx Pharma 57 BLA filing 57 aclidinium 57 Tarceva TM 57 TH# [003] 57 Cycloset 56 Androxal TM 56 Aplidin 56 Avanir 56 relapsed refractory multiple myeloma 56 PegIntron 56 galiximab 56 Ferumoxytol 56 Genentech Roche 56 Boceprevir 56 Phase #/#a trial 56 Adventrx 56 AFREZZA 56 Cladribine Tablets 56 LEVADEX 56 cladribine 56 Vaprisol 56 Erbitux cetuximab 56 Carfilzomib 56 Factor VIIa 56 hyperuricemia 56 HUMIRA 56 Orencia 56 raltegravir 56 DPX Survivac 56 denufosol 56 adecatumumab 56 Targeted Chemotherapy 56 AZILECT R 56 Teriflunomide 56 Phase III Clinical Trial 56 Glybera R 56 Catena ® 56 Corcept 56 Zelrix 56 Zenvia 56 GLPG# 56 ONGLYZA ™ 56 ToGA 56 SUTENT ® 56 MACUGEN 56 TriRima 56 Dificid 56 SAR# [002] 56 SCOLR Pharma 56 investigational humanized monoclonal antibody 56 eritoran 56 BEMA TM Fentanyl 56 antisense drug 56 CORT # 56 oral taxane 56 Memryte 56 LCP AtorFen 56 Erbitux 56 vorinostat 56 fingolimod 56 standard chemotherapy regimen 56 ZETIA 56 maximally tolerated dose 56 angiogenesis inhibitor 56 subcutaneous formulation 56 pazopanib 56 Adcirca 56 ARRY 56 castration resistant prostate cancer 56 INCB# [003] 56 Lung Rx 56 Maraviroc 56 ITMN 56 veltuzumab 56 dose escalation Phase 56 BLA submission 56 Mepact 56 Personalized Immunotherapy 56 mapatumumab 56 Omnitarg 56 Panitumumab 56 DEB# 56 Phase 2b Clinical Trial 56 Onconase 56 Flutiform TM 56 Unit Dose Budesonide 56 Fabry Disease